What we do

Bionaturis is a biotechnology-based group offering premium solutions for human and animal health applications. The biotechnology group is listing on the Spanish stock exchange for SMEs (trading code BNT).

           (For further information about the company, please, click here)

Vision and mission

  • Vision: To provide a global access to health
  • Mission: Putting ultimate health technologies and products at a more global reach of customers and users
  • Current strategic core business: biological drug development for animal health

The Group comprises 4 companies (Bionaturis, Biobide, ZIP Solutions, and BNT Pacific LTD) and 2 subsidiaries (BNT China Biosciences and Biobide USA) in 6 different locations (3xSpain, USA, Hong Kong, and China), offering products and services for human and animal applications throughout the following main divisions:

  • Human and animal health division. B2B business model to develop best-in-class products for human and animal health applications (Bionaturis). (For further information, please, click here)
  • CRO division. Zebrafish Toxicity and Efficacy assays for Early Discovery and Development (Biobide(For further information, please, click here)
  • CDMO division. Expression and purification services for third-parties (Bionaturis and ZIP Solutions) Further information about FLYLIFE and ZIP Solutions(For further information ,please, click here)
  • Consumer products. Development and marketing of dermocosmetic products. (For further information, please, click here)

The matrix company of the Group, Bionaturis, is positioned as a partner of reference for biological drug development in animal health. By a B2B business model Bionaturis co-develops best-in-class -prescription and non-prescription- products, partnering up with third parties with registration expertise and sales force in target markets.

Visit our Youtube channel here youtube-channel-logo